Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIFLUOPERAZINE HYDROCHLORIDE (trifluoperazine hydrochloride)

Snippet

SUPPL AP for TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)